[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100651095":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":30,"centralContacts":34,"locations":26,"responsibleParty":41,"collaborators":44,"id":73,"slug":74,"hasResults":75,"nctId":76,"briefTitle":77,"officialTitle":78,"acronym":26,"eligibilityCriteria":79,"healthyVolunteers":75,"sex":80,"minAge":81,"maxAge":26,"enrollmentInfo":82,"targetDuration":26,"studyType":85,"phases":86,"briefSummary":88,"conditions":89,"keywords":92,"overallStatus":95,"whyStopped":26,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":100,"completionDateStruct":102,"leadSponsor":104,"locationsCount":26},{"fullName":5,"class":6},"The Affiliated Hospital of Qingdao University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"prehabilitation group","EXPERIMENTAL","The prehabilitation group will receive preoperative multimodal prehabilitation combined with ERAS before gastrectomy.",[13],"Behavioral: mHealth prehabilitation group",{"label":15,"type":16,"description":17,"interventionNames":18},"ERAS group","PLACEBO_COMPARATOR","The ERAS group patients will be managed according to the ERAS pathway.",[19],"Other: ERAS group",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"BEHAVIORAL","mHealth prehabilitation group","receiving at least 4 weeks of 5G+AI digitally supervised home-based multi-modal prehabilitation plus standard ERAS perioperative management",[9],null,{"type":6,"name":15,"description":28,"armGroupLabels":29,"otherNames":26},"The management of ERAS group was carried out in accordance with the standard ERAS protocol from admission until 30 days postdischarge. The ERAS program mainly included malnutrition screening, health education, surgical risk assessment, and smoking and drinking cessation.",[15],[31],{"name":32,"affiliation":5,"role":33},"Yanbing Zhou","PRINCIPAL_INVESTIGATOR",[35,40],{"name":36,"role":37,"phone":38,"phoneExt":26,"email":39},"Yulong Tian","CONTACT","86532-82911324","zhouyanbing@qduhospital.cn",{"name":32,"role":37,"phone":38,"phoneExt":26,"email":39},{"type":33,"investigatorFullName":42,"investigatorTitle":43,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"Zhou Yanbing","The Director of the Department of Gastrointestinal Surgery, the Affiliated Hospital of Qingdao University",[45,47,49,51,54,56,58,61,63,65,67,69,71],{"name":46,"class":6},"People's Hospital of Xinjiang Uygur Autonomous Region",{"name":48,"class":6},"First Affiliated Hospital, Sun Yat-Sen University",{"name":50,"class":6},"Sixth Affiliated Hospital, Sun Yat-sen University",{"name":52,"class":53},"Shandong Provincial Hospital","OTHER_GOV",{"name":55,"class":6},"The Second Hospital of Shandong University",{"name":57,"class":6},"Yantai Yuhuangding Hospital",{"name":59,"class":60},"The Affiliated Hospital of Shandong Second Medical University","UNKNOWN",{"name":62,"class":6},"Weifang People's Hospital",{"name":64,"class":6},"Shandong Cancer Hospital and Institute",{"name":66,"class":6},"Dongying People's Hospital",{"name":68,"class":6},"Rizhao People's Hospital",{"name":70,"class":6},"Jining First People's Hospital",{"name":72,"class":60},"Peking University Cancer Hospital (Inner Mongolia Campus)","100651095","preoperative-home-based-multimodal-prehabilitation-based-on-5g--artificial-intelligence-mobile-health-100651095",false,"NCT07755917","Preoperative Home-based Multimodal Prehabilitation Based on 5G + Artificial Intelligence Mobile Health","Preoperative Multi-mode Prehabilitation Management for Neoadjuvant Chemotherapy Gastric Cancer Patients Supervised at Home Based on 5G + AI Mobile Health (mHealth): A Multicenter RCT","Inclusion Criteria:\n\n* Aged 18 years or older\n* Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1\n* Histologically confirmation of gastric or gastroesophageal junction (GEJ) adenocarcinoma. For GEJ carcinomas, eligibility is strictly confined to those presenting with Siewert type III tumors or Siewert type II tumors that do not mandate a concurrent thoracotomy\n* Surgery is planned after neoadjuvant therapy\n* Capacity to comprehend and voluntarily sign a written informed consent form\n* Ability to use digital technology (e.g., smart phones, wearable devices) independently or with the assistance of family members\n\nExclusion Criteria:\n\n* Distant metastasis\n* Severe cardiac dysfunction (preoperative LVEF \\\u003C 30% or NYHA classification IV), severe liver dysfunction (Child-Pugh C grade), severe kidney dysfunction (preoperative CRRT was received), ASA grade IV or above; 6MWD ≤ 250 meters\n* Within 6 months before enrollment, the patient had experienced cerebral hemorrhage, cerebral infarction, TIA, or suffered from central nervous system diseases or mental disorders, and was unable to cooperate in completing neoadjuvant therapy and prehabilitation\n* Presence of severe systemic infections (e.g., multiple organ dysfunction syndrome \\[MODS\\]) or active infectious diseases (e.g., tuberculosis)\n* Emergency surgery is required due to complications of the tumor (e.g. bleeding, perforation, obstruction)\n* Simultaneous tumors or other diseases requiring simultaneous surgery (excluding laparoscopic cholecystectomy)\n* Patients who are participating in any other clinical trials (except observational, non-interventional clinical study)","ALL","18 Years",{"count":83,"type":84},490,"ESTIMATED","INTERVENTIONAL",[87],"NA","The goal of this prospective, multicenter, open-label randomized controlled clinical trial is to evaluate whether a home-based, digitally supervised multi-modal prehabilitation intervention can improve functional capacity, treatment tolerance, and short- and long-term clinical outcomes in gastric cancer patients who have completed 2-4 cycles of neoadjuvant chemotherapy and are scheduled for radical gastrectomy.",[90,91],"Gastric Cancer","Prehabilitation",[93,94],"gastric cancer","prehabilitation","NOT_YET_RECRUITING","2026-08-07",{"date":98,"type":99},"2026-08-10","ACTUAL",{"date":101,"type":84},"2026-08-31",{"date":103,"type":84},"2030-09-01",{"name":5,"class":6}]